Trials / Completed
CompletedNCT01912118
The Medasense Study
Measurement of Nociceptive Index During General Anesthesia in ASA 1-3 Patients Undergoing Elective Surgery Using the Nociception Level (NoL) Index
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Leiden University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Despite various efforts there is still the need for adequate monitoring of pain and nociception during anesthesia. In a previous protocol the investigators measured pain responses during anesthesia based on single end-points, eg heart rate,blood pressure and pulse transit time. None of these parameters provided sufficient information regarding nociception. The investigators therefore want to further investigate this matter using a composite parameter, the Nociception Level or NoL. The NoL is a novel index that measures the magnitude of the autonomic response to painful stimuli. The NoL combines information from several physiological parameters, which represent different autonomic pathways. The multi-parameter approach empowered with state-of-the-art signal processing and machine learning techniques. In the current study the investigators will measure the NoL in ASA 1-3 patients undergoing elective surgery under general anesthesia. The investigators will measure NoL responses and the occurrence of patient movement upon the administration of a painful stimulus: Introduction of the laryngoscope, Insertion of the endotracheal tube, Insertion of the gastric tube, Insertion of the bladder catheter and Skin incision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol | Propofol will be titrated via a target controlled infusion to reach a specific target BIS (as specified in treatment arm) |
| DRUG | Remifentanil | Remifentanil will be provided by a target controlled infusion to a specific effect site concentration (as specified in treatment arm) |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-06-01
- Completion
- 2014-09-01
- First posted
- 2013-07-30
- Last updated
- 2015-04-06
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01912118. Inclusion in this directory is not an endorsement.